Back to Journals » Biologics: Targets and Therapy » Volume 13

Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience

Total article views   HTML views PDF downloads Totals
10,714 Dovepress* 9,835+ 1,870 11,705
PubMed Central* 879 356 1,235
Totals 10,714 2,226 12,940
*Since 3 January 2019
Total mentioned Facebook Delicious Reddit Twitter Others
9 0 0 0 1 8

View citations on PubMed Central and Google Scholar